Mizuho Initiates Coverage on LifePoint Health (LPNT)

Mizuho began coverage on shares of LifePoint Health (NASDAQ:LPNT) in a research note issued on Friday. The brokerage set a “neutral” rating on the stock.

Several other equities analysts also recently commented on LPNT. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Morgan Stanley restated an “equal weight” rating and issued a $46.00 price target (down from $50.00) on shares of LifePoint Health in a research note on Monday, February 26th. SunTrust Banks decreased their price target on shares of LifePoint Health to $44.00 and set a “hold” rating on the stock in a research note on Monday, February 26th. ValuEngine downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Zacks Investment Research upgraded shares of LifePoint Health from a “strong sell” rating to a “hold” rating in a research note on Monday, January 22nd. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $55.18.

How to Become a New Pot Stock Millionaire

LifePoint Health (NASDAQ:LPNT) opened at $48.25 on Friday. The firm has a market cap of $1,935.24, a PE ratio of 19.61, a PEG ratio of 1.50 and a beta of 0.57. LifePoint Health has a 1 year low of $41.45 and a 1 year high of $67.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.70 and a quick ratio of 1.49.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, February 23rd. The company reported $0.77 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.04). The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. LifePoint Health’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.07 earnings per share. sell-side analysts predict that LifePoint Health will post 4.27 EPS for the current fiscal year.

In other news, insider David M. Dill sold 45,000 shares of the stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total value of $2,183,400.00. Following the completion of the transaction, the insider now owns 252,673 shares of the company’s stock, valued at $12,259,693.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman William F. Carpenter III bought 21,368 shares of the company’s stock in a transaction dated Wednesday, February 28th. The stock was bought at an average cost of $46.80 per share, with a total value of $1,000,022.40. Following the acquisition, the chairman now directly owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The disclosure for this purchase can be found here. Corporate insiders own 8.76% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of LPNT. Millennium Management LLC raised its holdings in LifePoint Health by 583.3% in the 4th quarter. Millennium Management LLC now owns 947,579 shares of the company’s stock valued at $47,189,000 after buying an additional 808,906 shares during the last quarter. American Century Companies Inc. raised its holdings in LifePoint Health by 16.3% in the 4th quarter. American Century Companies Inc. now owns 4,220,590 shares of the company’s stock valued at $210,185,000 after buying an additional 590,103 shares during the last quarter. Boston Partners raised its holdings in LifePoint Health by 50.8% in the 4th quarter. Boston Partners now owns 874,690 shares of the company’s stock valued at $43,559,000 after buying an additional 294,480 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in LifePoint Health by 28.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock valued at $46,044,000 after buying an additional 177,329 shares during the last quarter. Finally, First Trust Advisors LP raised its holdings in LifePoint Health by 33.4% in the 4th quarter. First Trust Advisors LP now owns 414,248 shares of the company’s stock valued at $20,630,000 after buying an additional 103,680 shares during the last quarter.

TRADEMARK VIOLATION WARNING: “Mizuho Initiates Coverage on LifePoint Health (LPNT)” was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3298066/mizuho-initiates-coverage-on-lifepoint-health-lpnt.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

RSP Permian  Given a $69.00 Price Target by Stephens Analysts
RSP Permian Given a $69.00 Price Target by Stephens Analysts
Sandler O’Neill Analysts Give Simmons First National  a $35.00 Price Target
Sandler O’Neill Analysts Give Simmons First National a $35.00 Price Target
Wells Fargo Downgrades Emergent BioSolutions  to Market Perform
Wells Fargo Downgrades Emergent BioSolutions to Market Perform
Targa Resources  PT Set at $53.00 by Seaport Global Securities
Targa Resources PT Set at $53.00 by Seaport Global Securities
Cognex  Raised to Buy at Zacks Investment Research
Cognex Raised to Buy at Zacks Investment Research
Gold Corporation Barrick Buys 1,293,324 Shares of Royal Road Minerals  Stock
Gold Corporation Barrick Buys 1,293,324 Shares of Royal Road Minerals Stock


© 2006-2018 Ticker Report. Google+.